C-Path Initiative’s Work on Personalized Medicine Starts to Get Results The Critical path Institute (C-Path), the US Food and Drug Administration (FDA)-supported public-private initiative working to adv
C-Path Recognized in One of The National Institute of Mental Health’s Top 10 Research Advances of 2011
Critical Path Institute and Hamner Institutes for Health Sciences Announce Collaboration to Improve Safety of Medical Product Development Critical Path Institute(C-Path)and The Hamner Institutes for Health Sciences (The Hamner) announced today that they have signed a
Critical Path Institute Gathers Cross-Sector Innovators at Global Conference on Drug Development Hundreds of leaders from cross-sector arenas in government, academia, the biotechnology and pharmaceutical industry, and patient a
March 11, 2011 Mixing Modes of Patient-Reported Outcomes Data Collection in Clinical Trials: Recommendations
The Development of a SPSS Data Dictionary and Syntax for Optimizing the Utilization of the Coalition Against Major Diseases (CAMD) AD Clinical Trial Datasets
Critical Path Institute and Innovative Medicines Initiative Announce Formal Collaboration Internationally renowned organizations share common commitment to advancing science that improves medical product development. Cri